Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Caron

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2019
Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid GlucuronidationJoanie Vaillancourt, Véronique Turcotte, Patrick Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathwayEric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
Endocrine-Related Cancer|December 3, 2014
The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomyIsabelle Laverdière, Christine Flageole, Étienne Audet-Walsh, et al.
Urologic Oncology|April 19, 2022
Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT)Raj Tiwari, Katherine Lajkosz, MohamadBaker Berjaoui, et al.
Drug Metabolism Reviews|October 17, 2009
Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potentialMélanie Verreault, Jenny Kaeding, Patrick Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancerÉric Lévesque, Isabelle Laverdière, Louis Lacombe, et al.
Pharmacogenetics and Genomics|November 6, 2009
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4Marie-Odile Benoit-Biancamano, Jean-Philippe Adam, Olivier Bernard, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liverJocelyn Trottier, Mélanie Verreault, Susan Grepper, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 3, 2017
Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgeryYannick Audet-Delage, Jean Grégoire, Patrick Caron, et al.
Clinical and Experimental Medicine|July 30, 2024
Targeting sphingolipid metabolism in chronic lymphocytic leukemiaFlora Nguyen Van Long, Trang Le, Patrick Caron, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2019
Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid GlucuronidationJoanie Vaillancourt, Véronique Turcotte, Patrick Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathwayEric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
Endocrine-Related Cancer|December 3, 2014
The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomyIsabelle Laverdière, Christine Flageole, Étienne Audet-Walsh, et al.
Urologic Oncology|April 19, 2022
Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT)Raj Tiwari, Katherine Lajkosz, MohamadBaker Berjaoui, et al.
Drug Metabolism Reviews|October 17, 2009
Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potentialMélanie Verreault, Jenny Kaeding, Patrick Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancerÉric Lévesque, Isabelle Laverdière, Louis Lacombe, et al.
Pharmacogenetics and Genomics|November 6, 2009
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4Marie-Odile Benoit-Biancamano, Jean-Philippe Adam, Olivier Bernard, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liverJocelyn Trottier, Mélanie Verreault, Susan Grepper, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 3, 2017
Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgeryYannick Audet-Delage, Jean Grégoire, Patrick Caron, et al.
Clinical and Experimental Medicine|July 30, 2024
Targeting sphingolipid metabolism in chronic lymphocytic leukemiaFlora Nguyen Van Long, Trang Le, Patrick Caron, et al.
Pageof 10